Chemotherapy in non-small cell lung cancer: opportunities for advancement

Locally advanced non-small cell lung cancer (NSCLC) continues to be a challenging disease to treat. With high rates of both local and distant failures, there is significant interest in finding more biologically active chemotherapy regimens that can contribute to reduce both failures. The phase III P...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtari, Mani, Bernicker, Eric H., Teh, Bin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917936/
https://www.ncbi.nlm.nih.gov/pubmed/27339154
http://dx.doi.org/10.1186/s40880-016-0119-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917936/
https://www.ncbi.nlm.nih.gov/pubmed/27339154
http://dx.doi.org/10.1186/s40880-016-0119-x

Ejemplares similares